Question follow-through · 114042
Prostate Cancer: Screening
To ask the Secretary of State for Health and Social Care, whether his Department has conducted a cost-benefit analysis of offering routine prostate-specific antigen testing to high-risk groups.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 20 Feb 2026
- Target answer date
- 24 Feb 2026
- Answer
- 3 Mar 2026 · 11 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
20 Feb 2026
Question tabled
To ask the Secretary of State for Health and Social Care, whether his Department has conducted a cost-benefit analysis of offering routine prostate-specific antigen testing to high-risk groups.
24 Feb 2026
Target answer date
Date supplied by the official written-questions record.
3 Mar 2026
Answer published
The Government is guided by the independent scientific advice of the UK National Screening Committee (UK NSC). It is only where the offer to screen provides more good than harm that a screening programme is recommended. The UK NSC makes its recommendation...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.